Survival patterns in United States (US) medicare enrollees with non-CML myeloproliferative neoplasms (MPN).

by Gregory L Price, Keith L Davis, Sudeep Karve, Gerhardt Pohl, Richard A Walgren
Published 2014-01-01

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

by Talia Golan, Ravit Geva, Donald Richards, Srinivasan Madhusudan, Boris Kin Lin, Haofei Tiffany Wang, Richard A. Walgren, Salomon M. Stemmer
Published 2018-10-01

Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis.

by Timothy A Graubert, Michelle A Payton, Jin Shao, Richard A Walgren, Ryan S Monahan, John L Frater, Mark A Walshauser, Mike G Martin, Yumi Kasai, Matthew J Walter
Published 2009-01-01